Full Professor(heuristic)

Prostate Cancer Treatment and Research · Pulmonary and Respiratory Medicine

h-index81
i10-index278
Publications794
Citations32,574

Grants

37 total · 15 active

NIH #5U01FD007857-03

Research Triangle Center of Excellence in Regulatory Science and Innovation

Expiring Soon
Amount
$525K
Period
2023-09-01 → 2026-08-31
PIs
4
Est. capacity / PI
~0 students

Awarded at UNIV OF NORTH CAROLINA CHAPEL HILL

NIH #5R01CA249279-04

Interactions of Androgen Production, Uptake and Metabolism on outcome in Castration Resistant Prostate Cancer

Expiring Soon
Amount
$523K
Period
2021-09-01 → 2026-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DUKE UNIVERSITY

NIH #7R01CA249279-03

Interactions of Androgen Production, Uptake and Metabolism on outcome in Castration Resistant Prostate Cancer

Expiring Soon
Amount
$466K
Period
2021-09-01 → 2026-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DUKE UNIVERSITY

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

All Grants

37 total · 15 active

NIH #5U01FD007857-03

Research Triangle Center of Excellence in Regulatory Science and Innovation

Expiring Soon
Amount
$525K
Period
2023-09-01 → 2026-08-31
PIs
4
Est. capacity / PI
~0 students

Awarded at UNIV OF NORTH CAROLINA CHAPEL HILL

NIH #5R01CA249279-04

Interactions of Androgen Production, Uptake and Metabolism on outcome in Castration Resistant Prostate Cancer

Expiring Soon
Amount
$523K
Period
2021-09-01 → 2026-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DUKE UNIVERSITY

NIH #7R01CA249279-03

Interactions of Androgen Production, Uptake and Metabolism on outcome in Castration Resistant Prostate Cancer

Expiring Soon
Amount
$466K
Period
2021-09-01 → 2026-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DUKE UNIVERSITY

NIH #1R01CA249279-01A1

Interactions of Androgen Production, Uptake and Metabolism on outcome in Castration Resistant Prostate Cancer

Expiring Soon
Amount
$427K
Period
2021-09-01 → 2026-08-31
PIs
3
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF MINNESOTA

NIH #3U01FD007857-02S3

Research Triangle Center of Excellence in Regulatory Science and Innovation

Active
Amount
$451K
Period
2023-09-01 → 2028-08-31
PIs
4
Est. capacity / PI
~0 students

Awarded at UNIV OF NORTH CAROLINA CHAPEL HILL

NIH #3U01FD007857-02S2

Research Triangle Center of Excellence in Regulatory Science and Innovation

Active
Amount
$2.0M
Period
2023-09-01 → 2028-08-31
PIs
4
Est. capacity / PI
~3 students

Awarded at UNIV OF NORTH CAROLINA CHAPEL HILL

NIH #3U01FD007857-02S5

Research Triangle Center of Excellence in Regulatory Science and Innovation

Active
Amount
$868K
Period
2023-09-01 → 2028-08-31
PIs
4
Est. capacity / PI
~1 students

Awarded at UNIV OF NORTH CAROLINA CHAPEL HILL

NIH #3U01FD007857-02S1

Research Triangle Center of Excellence in Regulatory Science and Innovation

Active
Amount
$668K
Period
2023-09-01 → 2028-08-31
PIs
4
Est. capacity / PI
~1 students

Awarded at UNIV OF NORTH CAROLINA CHAPEL HILL

NIH #5U01FD007857-02

Research Triangle Center of Excellence in Regulatory Science and Innovation

Active
Amount
$750K
Period
2023-09-01 → 2028-08-31
PIs
4
Est. capacity / PI
~1 students

Awarded at UNIV OF NORTH CAROLINA CHAPEL HILL

NIH #3U01FD007857-02S7

Research Triangle Center of Excellence in Regulatory Science and Innovation

Active
Amount
$376K
Period
2023-09-01 → 2028-08-31
PIs
4
Est. capacity / PI
~0 students

Awarded at UNIV OF NORTH CAROLINA CHAPEL HILL

NIH #3U01FD007857-02S6

Research Triangle Center of Excellence in Regulatory Science and Innovation

Active
Amount
$949K
Period
2023-09-01 → 2028-08-31
PIs
4
Est. capacity / PI
~1 students

Awarded at UNIV OF NORTH CAROLINA CHAPEL HILL

NIH #3U01FD007857-02S4

Research Triangle Center of Excellence in Regulatory Science and Innovation

Active
Amount
$454K
Period
2023-09-01 → 2028-08-31
PIs
4
Est. capacity / PI
~0 students

Awarded at UNIV OF NORTH CAROLINA CHAPEL HILL

NIH #1U01FD007857-01

Research Triangle Center of Excellence in Regulatory Science and Innovation

Active
Amount
$4.9M
Period
2023-09-01 → 2028-08-31
PIs
4
Est. capacity / PI
~8 students

Awarded at UNIV OF NORTH CAROLINA CHAPEL HILL

NIH #5UH3CA260389-05

Validation of predictive liquid biomarkers for patients with metastatic prostate cancer

Active
Amount
$329K
Period
2021-06-01 → 2027-05-31
PIs
4
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF WISCONSIN-MADISON

NIH #5R01CA256157-05

Clinical genomic predictive model of first line androgen receptor inhibitor therapy outcomes in men with mCRPC

Active
Amount
$647K
Period
2020-09-16 → 2026-12-31
PIs
3
Est. capacity / PI
~0 students

Awarded at DUKE UNIVERSITY

NIH #5UH3CA260389-04

Validation of predictive liquid biomarkers for patients with metastatic prostate cancer

Amount
$319K
Period
2021-06-01 → 2026-05-31
PIs
4
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF WISCONSIN-MADISON

NIH #4UH3CA260389-03

Validation of predictive liquid biomarkers for patients with metastatic prostate cancer

Amount
$363K
Period
2021-06-01 → 2026-05-31
PIs
4
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF WISCONSIN-MADISON

NIH #5R21CA263950-02

Sieve based full likelihood approach for the Cox proportional hazards model with applications to immunotherapies trials

Amount
$179K
Period
2023-02-22 → 2026-01-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DUKE UNIVERSITY

NIH #5R01CA256157-04

Clinical genomic predictive model of first line androgen receptor inhibitor therapy outcomes in men with mCRPC

Amount
$612K
Period
2020-09-16 → 2025-12-31
PIs
3
Est. capacity / PI
~0 students

Awarded at DUKE UNIVERSITY

NIH #5R01CA256157-03

Clinical genomic predictive model of first line androgen receptor inhibitor therapy outcomes in men with mCRPC

Amount
$637K
Period
2020-09-16 → 2025-12-31
PIs
3
Est. capacity / PI
~0 students

Awarded at DUKE UNIVERSITY

NIH #5R01CA256157-02

Clinical genomic predictive model of first line androgen receptor inhibitor therapy outcomes in men with mCRPC

Amount
$633K
Period
2020-09-16 → 2025-12-31
PIs
3
Est. capacity / PI
~0 students

Awarded at DUKE UNIVERSITY

NIH #1R01CA256157-01

Clinical genomic predictive model of first line androgen receptor inhibitor therapy outcomes in men with mCRPC

Amount
$653K
Period
2020-09-16 → 2025-12-31
PIs
3
Est. capacity / PI
~0 students

Awarded at DUKE UNIVERSITY

NIH #1R21CA263950-01A1

Sieve based full likelihood approach for the Cox proportional hazards model with applications to immunotherapies trials

Amount
$226K
Period
2023-02-22 → 2025-01-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DUKE UNIVERSITY

NIH #5R01CA249279-02

Interactions of Androgen Production, Uptake and Metabolism on outcome in Castration Resistant Prostate Cancer

Amount
$641K
Period
2021-09-01 → 2023-08-31
PIs
3
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF MINNESOTA

NIH #5UH2CA260389-02

Validation of predictive liquid biomarkers for patients with metastatic prostate cancer

Amount
$160K
Period
2021-06-01 → 2023-05-31
PIs
4
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF WISCONSIN-MADISON

NIH #1UH2CA260389-01

Validation of predictive liquid biomarkers for patients with metastatic prostate cancer

Amount
$191K
Period
2021-06-01 → 2023-05-31
PIs
4
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF WISCONSIN-MADISON

NIH #5R21CA195424-02

Serum Androgens as Predictors of Survival in Metastatic Prostate Cancer

Amount
$207K
Period
2015-05-05 → 2018-04-30
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

NIH #5U01CA157703-05

Validation of prognostic and pathway signatures in lethal prostate cancer

Amount
$454K
Period
2011-09-26 → 2017-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DUKE UNIVERSITY

NIH #1R21CA195424-01

Serum Androgens as Predictors of Survival in Metastatic Prostate Cancer

Amount
$191K
Period
2015-05-05 → 2017-04-30
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

NIH #5U01CA157703-04

Validation of prognostic and pathway signatures in lethal prostate cancer

Amount
$440K
Period
2011-09-26 → 2016-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DUKE UNIVERSITY

NIH #7U01CA157703-03

Validation of prognostic and pathway signatures in lethal prostate cancer

Amount
$511K
Period
2011-09-26 → 2016-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DUKE UNIVERSITY

NIH #1U01CA157703-01

Validation of prognostic and pathway signatures in lethal prostate cancer

Amount
$603K
Period
2011-09-26 → 2016-08-31
PIs
3
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

NIH #5R01CA155296-04

Prognostic Models of Clinical Outcomes In Men With Castration Resistant Prostate

Amount
$232K
Period
2011-07-06 → 2016-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DUKE UNIVERSITY

NIH #5R01CA155296-03

Prognostic Models of Clinical Outcomes In Men With Castration Resistant Prostate

Amount
$224K
Period
2011-07-06 → 2015-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DUKE UNIVERSITY

NIH #5R01CA155296-02

Prognostic Models of Clinical Outcomes In Men With Castration Resistant Prostate

Amount
$242K
Period
2011-07-06 → 2015-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DUKE UNIVERSITY

NIH #1R01CA155296-01A1

Prognostic Models of Clinical Outcomes In Men With Castration Resistant Prostate

Amount
$215K
Period
2011-07-06 → 2015-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DUKE UNIVERSITY

NIH #5U01CA157703-02

Validation of prognostic and pathway signatures in lethal prostate cancer

Amount
$525K
Period
2011-09-26 → 2013-08-16
PIs
3
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 83
Open author page on OpenAlex →